Date	Period	Revenue/Estimate	Earnings Call
Apr 24, 2025	2025/Q1	-- / 6.000B	--
--	2024/Q4	-- / 5.817B	--
Oct 29, 2024	2024/Q3	4.962B / 5.723B	--
Aug 29, 2024	2024/Q2	5.608B / 5.650B	--
Apr 25, 2024	2024/Q1	6.219B / 5.897B	--

DatePeriodRevenue/EstimateEarnings Call

Apr 24, 20252025/Q1-- / 6.000B--

--2024/Q4-- / 5.817B--

Oct 29, 20242024/Q34.962B / 5.723B--

Aug 29, 20242024/Q25.608B / 5.650B--

Apr 25, 20242024/Q16.219B / 5.897B--

Unlock Free Earnings Estimates

Open Account

Sichuan Kelun Pharmaceutical Earnings Reports

Colon Pharmaceuticals: Report for the third quarter of 2024

Oct 28, 2024 12:00 ET

Colon Pharmaceuticals: Semi-Annual Report 2024

Aug 28, 2024 12:00 ET

Colon Pharmaceuticals: 2024 Semi-Annual Report Summary

Aug 28, 2024 12:00 ET

Sichuan Kelun Pharmaceutical: 2024 Half-Year Performance Bulletin

Aug 12, 2024 12:00 ET

Top CN Stock Gainers

Symbol Price % Chg

Shenzhen Kaifa Technology

920029

76.06 +150.36%

Shanghai Yongli Belting

300230

5.93 +20.04%

Guomai Culture & Media

301052

33.42 +20.00%

WuHan Hvsen Biotechnology

See the daily top gainer.

Analysis

Analyst Rating

Updated: Mar 28, 2025

Strong Buy

Strong Buy
95.65%
Buy
4.35%
Hold
0.00%
Underperform
0.00%
Sell
0.00%

Price Target

No Data